Imatinib and beyond—the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia

By Berger U.  

Annals of Hematology, Vol. 83, Iss. 4, 2004-04 ,pp. : 258-264

Springer Publishing Company

Access to resources Recommend Favorite

EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’ better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

By Uz Burak   Buyukasik Yahya   Atay Hilmi   Kelkitli Engin   Turgut Mehmet   Bektas Ozlen   Eliacik Eylem   Isik Ayşe   Aksu Salih   Goker Hakan   Sayinalp Nilgun   Ozcebe Osman I.   Haznedaroglu Ibrahim C.  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 247-252

Maney Publishing

Access to resources Recommend Favorite

Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

By Koh Youngil   Kim Inho   Yoon Sung-Soo   Kim Byoung   Kim Dae-Young   Lee Je-Hwan   Lee Kyoo-Hyung   Park Eunkyung   Kim Hyeoung-Joon   Sohn Sang   Joo Young   Kim Seok   Chung Jooseop   Shin Ho-Jin   Kim Sung-Hyun   Kim Chul   Song Hong   Kim Min   Hyun Myung   Ahn Jin   Jung Chul   Park Seonyang  

Annals of Hematology, Vol. 89, Iss. 7, 2010-07 ,pp. : 725-731

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib-induced Stevens–Johnson syndrome: recurrence after re-challenge with a lower dose

By Mahapatra Manoranjan   Mishra Pravas   Kumar Rajat  

Annals of Hematology, Vol. 86, Iss. 7, 2007-07 ,pp. : 537-538

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

By Usuki Kensuke  

International Journal of Hematology, Vol. 95, Iss. 4, 2012-04 ,pp. : 409-419

Springer Publishing Company

Access to resources Recommend Favorite